Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: IOP Reduction in Pigmentary Glaucoma Using DSLT

View source ↗

Summary

A clinical trial evaluating whether direct selective laser trabeculoplasty (DSLT) lowers intraocular pressure in pigmentary dispersion syndrome and pigmentary d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Direct Selective Laser Trabeculoplasty (DSLT) (DSLT)

Snippet

Sponsor: Mann Eye Institute | Conditions: Pigmentary Dispersion Syndrome, Pigmentary Dispersion Glaucoma | Status: RECRUITING